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Abstract
Stat3 has a defined role in mammary gland where it is a critical mediator of cell death during post-lactational regression. On
the other hand, Stat3 is required for the self-renewal of embryonic stem cells and is sufficient for the induction of a naı¨ve
pluripotent state in epiblast stem cells. Mammary stem cells (MaSCs) have a high capacity for self-renewal and can grow
robustly in transplantation experiments in vivo. However, a role for Stat3 in MaSCs has not been investigated. Here we show
that depletion of Stat3 from basal cells results in reduced primary transplantation efficiency and diminishes the potential to
generate ductal, but not alveolar, outgrowths. In addition, Stat3 is required for maximal proliferation of luminal progenitors.
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Introduction
The transcription factor Signal Transducer and Activator of
Transcription (Stat) 3 is constitutively expressed in a wide variety
of tissues. Stat3 is activated by various cytokines and growth
factors such as OSM, LIF, IL-6, IL-10, IL-17, IL-23, leptin, EGF,
and interferons, as well as the proto-oncogenes and oncogenes c-
Src, c-Abl, Met, and ErbB2 [1]. Leukaemia inhibitory factor (LIF),
which belongs to the IL-6 family of cytokines, is indispensable for
self-renewal of mouse embryonic stem cells (mESCs) and
maintenance of their undifferentiated state [2]. LIF, after binding
to the LIFR/gp130 heterodimer, can trigger three signalling
pathways, namely JAK/Stat3, PI3K/Akt and SHP2/MAPK.
However, the Stat3 branch of LIF signalling has been demon-
strated to play a central role in the regulation of self-renewal and
pluripotency of mESCs [3]. In fact, overexpression of a dominant
negative variant of Stat3 in mESCs leads to loss of pluripotency
and enhanced cell differentiation [4]. Furthermore, Stat3 activa-
tion is sufficient to maintain the undifferentiated state of mESCs,
as demonstrated in a study using a fusion protein between Stat3
and the ligand binding domain of the estrogen receptor (ER) [5].
Additionally, deletion of Stat3 causes embryonic lethality as Stat32/
2 embryos have reduced growth of the inner cell mass (ICM) and
show rapid degeneration between days E6.5– E7.5 [6]. Thus, Cre-
loxP systems have been used to investigate the role of Stat3 in
different cell types. In the small intestine, Stat3 is absolutely
required for survival of the stem cells near the base of the crypt [7]
and expression of dominant negative Stat3 in hematopoietic stem
cells results in a reduced lympho-myeloid reconstituting ability [8].
In the mammary gland Stat3 is activated early during post-
lactational regression and is a major regulator of the extensive cell
death and tissue remodelling that occurs during this process [9,10].
Recently, we demonstrated that activation of Stat3 is required
during mammary gland involution to upregulate the expression of
the lysosomal proteases, cathepsins B and L, and to downregulate
the expression of their endogenous cytoplasmic inhibitor (Spi2A)
thereby mediating cell death [11]. However, a potential role for
Stat3 in mammary stem cells has not been determined.
Mammary epithelium consists of luminal (ductal and alveolar)
and basal (myoepithelial) cells that are organised into a bi-layered
structure with luminal cells lining the lumen encased by an outer
layer of basal cells [12]. It is presumed that both luminal and basal
lineages originate from common embryonic stem and progenitor
cells. Moreover, each pregnancy cycle is accompanied by the
massive expansion of the mammary epithelial compartment which
suggests that the adult mammary gland contains a population of
stem/progenitor cells with long-term self-renewal potential [13].
Previous reports have confirmed that mammary stem cells
transplanted into a cleared fat pad can regenerate a functional
mammary epithelial tree [14,15,16,17]. Moreover, each full-term
pregnancy cycle generates so called parity-induced mammary
epithelial cells (PI-MECs) that produce milk proteins during late
gestation and lactation and do not undergo programmed cell
death during involution. Some of these cells act as alveolar
progenitors during subsequent pregnancies and in vivo transplan-
tation experiments proved their multipotency and self renewal
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capacity [18,19]. Furthermore, these PI-MECs were shown to
express cell surface markers that are associated with mammary
stem cells [19].
Isolation of a pure mammary stem cell population has not been
possible thus far due to lack of definitive markers. However, a
mammary stem cell-enriched population can be obtained using a
combination of cell surface markers and fluorescence-activated cell
sorting (FACS). The population of CD24+ CD49fhi cells contains
basal cells, mammary stem cells and possibly luminal progenitors.
Outgrowths arising from these cells are fully functional and able to
produce milk when recipients are put through pregnancy [20,21].
Moreover, mammary stem cells express basal markers such as
keratin (K) 5, K14, smooth muscle actin (SMA), smooth muscle
myosin, vimentin and laminin [20,22]. Luminal cells are CD24+
CD49flo, express K18 and lack expression of these basal markers.
Luminal progenitors can be distinguished by the expression of the
CD61 surface molecule and have the ability to form colonies
in vitro in both two-dimensional and three-dimensional Matrigel
culture [23].
Given the indispensable role of Stat3 in mESCs and intestinal
crypt stem cells, and the essential role of Stat3 in mediating cell
death during mammary gland involution, it was of interest to us to
investigate the role of Stat3 in mammary gland-specific stem cells
including both embryonic derived adult stem cells and those that
are present following a full involution (PI-MECs).
Materials and Methods
Animal Husbandry
Mice bearing a Stat3 gene flanked by loxP sites (Stat3fl/fl) [24]
were crossed with a strain expressing Cre recombinase gene under
either the b-lactoglobulin (BLG) promoter [25] or the K14
promoter. K14-Cre mice were kindly donated by Dr. Michaela
Frye (Centre for Stem Cell Research, Cambridge, UK), were
originally from The Jackson Laboratories (Bar Harbor, ME, USA),
and have a mixed C57Bl/6 6 CBA background. All mice were
maintained and bred in conventional cages within a specific
pathogen free (SPF) animal facility. Immunodeficient CD1-
Figure 1. Stat3fl/fl;BLG-Cre+ glands show incomplete involution and luminal progenitors have reduced proliferative capacity. (A) RT-
PCR analysis of Stat3 expression in FACS sorted populations of mammary epithelial cells. MRU: mammary repopulating units. (B, C) H&E staining of
sections of Stat3fl/fl;BLG-Cre2 and Stat3fl/fl;BLG-Cre+ mammary glands collected at day 5 of the second gestation (B) or four weeks after natural
weaning (C). (D) Western blot analysis of four Stat3fl/fl;BLG-Cre2 and five Stat3fl/fl;BLG-Cre+ mammary glands four weeks after natural weaning for the
expression or activation of Stat5, Erk, Akt, b-casein and WAP. b-actin was used as a loading control. (E) Immunohistochemistry staining for pStat5 (red)
and E-cadherin (green) in mammary gland sections from Stat3fl/fl;BLG-Cre2 and Stat3fl/fl;BLG-Cre+ mice collected four weeks after natural weaning.
Nuclei were stained with Hoechst 33342 (blue). (F) Flow cytometry analysis of luminal progenitors isolated from mammary glands of Stat3fl/fl;BLG-Cre2
and Stat3fl/fl;BLG-Cre+ females four weeks after natural weaning. (G) In vitro colony forming analysis performed on CD24+ CD49fhi CD61+ luminal
progenitor cells sorted from Stat3fl/fl;BLG-Cre2 and Stat3fl/fl;BLG-Cre+ mammary glands. Points represent the value for each mouse and lines depict
mean values for each group. p value was determined using Student’s t test, * p,0.05.
doi:10.1371/journal.pone.0052608.g001
Stat3 and Mammary Stem Cells
PLOS ONE | www.plosone.org 2 December 2012 | Volume 7 | Issue 12 | e52608
Foxn12/2 (nu/nu) nude mice were purchased from Charles River
at the age of 22–28 days and maintained in individually ventilated
cages (IVC) within a SPF animal facility. Animals were sacrificed
through CO2 inhalation and/or dislocation of the neck. All
animals were treated in strict accordance with the local ethical
committee (University of Cambridge Licence Review Committee)
and the UK Home Office guidelines. This study was specifically
approved and authorised under the Project Licence of CJW.
Genotype Analysis
In order to genotype Stat3fl/fl;BLG-Cre and Stat3fl/fl;K14-Cre mice
and outgrowths, genomic DNA was isolated and the following
primers were used in PCR reaction: BLG forward 59-TCG TGC
TTC TGA GCT CTG CAG-39, BLG reverse 59-GCT TCT
GGG GTC TAC CAG GAA-39, whey acidic protein (WAP)
control forward 59-CCT CCT CAG CAT AGA CA-39, WAP
control reverse 59-GGT GAT CAG TCA CTT GCC TGA-39,
K14 forward 59-TTC CTC AGG AGT GTC TTC GC-39, K14
reverse 59-GTC CAT GTC CTT CCT GAA GC-39, K14 control
forward 59-CAA ATG TTG CTT GTC TGG TG-39, K14
control reverse 59-GTC AGT CGA GTG CAC AGT TT-39, Stat3
wt and floxed forward 59-CAC CAA CAC ATG CTA TTT GTA
GG-39, Stat3 wt and floxed reverse 59-CCT GTC TCT GAC
AGG CCA TC-39, Stat3 deleted forward 59-CAC CAA CAC
ATG CTA TTT GTA GG-39, Stat3 deleted reverse 59-GCA GCA
GAA TAC TCT ACA GCT C-39.
Semi-quantitative RT-PCR
RNA was extracted from sorted cells using TRIzol Reagent
(Invitrogen) and cDNA was prepared using the Super Script First-
Strand Synthesis System for RT (Invitrogen) following the
manufacturer’s instructions. Semi-quantitative RT-PCR was
performed with the following primers: Stat3, 59-CAA TAC CAT
TGA CCT GCC GAT-39 and 59-GAG CGA CTC AAA CTG
CCC T-39; Cyclophilin A, 59-CCT TGG GCC GCG TCT CCT
T-39 and 59-CAC CCT GGC ACA TGA ATC CTG-39, and
products were analysed on an agarose gel.
Preparation of Single Cell Suspensions from Mammary
Glands
Mammary tissues were collected from animals and digested at
37uC for 12–16 h in DMEM/F12 (Invitrogen) with 1% HEPES
buffer (1 M, PAA) and 10 mg/ml collagenase (Roche) with
1000 U/ml hyaluronidase (Sigma). After the lysis of red blood
cells in NH4Cl, cells were briefly digested with warm 0.25%
Trypsin-EDTA, 5 mg/ml dispase (Sigma) and 1 mg/ml DNase
(Sigma), and filtered through a 40 mm cell strainer (BD).
FACS Analysis and Cell Sorting
Single cell suspensions were stained with biotinylated anti-
CD31, anti-CD45 and anti-Ter119 antibodies, anti-CD24-PE
(eBioscience), anti-CD49f-Alexa Flour 647, anti-CD61-Alexa
Fluor 488 (BioLegend), streptavidin-PE Texas Red (BD) and
propidium iodide (10 ng/ml; Sigma). Samples were filtered
through a 30 mm cell strainer (Partec) immediately prior to flow
cytometry analysis and sorting. Cells were either sorted using a
MoFlo XDP sorter (DakoCytomation) or analysed using a
Figure 2. BLG-Cre mediated deletion of Stat3 affects repopu-
lating frequency of stem cells and outgrowth phenotype. (A)
Whole mount staining of mammary outgrowths originating from CD24+
CD49fhi basal cells sorted from mammary glands of Stat3fl/fl,BLG-Cre2
and Stat3fl/fl;BLG-Cre+ females four weeks after natural weaning. (B)
Limiting dilution analysis of the repopulating frequency of the
mammary stem cell-enriched population sorted from mammary glands
of Stat3fl/fl,BLG-Cre2 and Stat3fl/fl;BLG-Cre+ females four weeks after
natural weaning. Number of outgrowths is shown per number of
transplanted fat pads. CI: confidence interval.
doi:10.1371/journal.pone.0052608.g002
Figure 3. Normal mammary gland development in Stat3
depleted glands. (A) Whole mount staining of mammary glands of
5-week-old Stat3fl/fl;K14-Cre2 and Stat3fl/fl;K14-Cre+ females. (B) Flow
cytometry analysis of luminal and basal cells isolated from mammary
glands of Stat3fl/fl;K14-Cre2 and Stat3fl/fl;K14-Cre+ females four weeks
after natural weaning. p value was determined using Student’s t test. ns:
not significant.
doi:10.1371/journal.pone.0052608.g003
Stat3 and Mammary Stem Cells
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CyAnTM ADP flow cytometer (DakoCytomation). The Summit
4.3 software (DakoCytomation) was used to analyse the data.
Haematoxylin and Eosin (H&E) Staining and
Immunohistochemistry
Haematoxylin and Eosin staining and immunohistochemistry
were carried out as previously described [11,26]. Primary
antibodies used were: rabbit anti-phospho Stat5 (Cell Signalling
Technology), mouse anti-E-cadherin (Cell Signalling Technology)
and rabbit anti-Ki67 (Abcam). Secondary antibodies used were:
Alexa Fluor 488 goat anti-mouse IgG (Invitrogen) and Cy3 goat
anti-rabbit IgG (Invitrogen). Nuclei were stained with Hoechst
33342 (Sigma). The pictures were acquired using a Zeiss Axioplan
2 microscope.
Whole Mounts
Mammary tissue was collected from female mice and stretched
on a glass slide. Slides were incubated in Metha-Carnoy’s Fixative
overnight and then stained with Carmine Alum overnight. After
the Carmine had penetrated the entire tissue, the slides were
placed in 100% ethanol for two hours and then in xylene for
several hours. Samples were photographed using a Leica MZ7.5
stereomicroscope with a Leica DFC280 camera and Adobe
Photoshop software.
Colony Assay
NIH-3T3 fibroblasts were cultured in DMEM supplemented
with 5% FCS and harvested from sub-confluent (,60%) cultures.
Cells were irradiated by X-ray at 220 kV/14 mA for 14 min.
Sorted mammary epithelial cells were collected in EpiCult-B
Medium (Stem Cell Technologies) containing irradiated NIH-3T3
fibroblasts (10000 cells/ml), seeded on 6 cm polystyrene dishes
(Nunc) and incubated at 37uC for one week. Then the colonies
were fixed with ice cold methanol : acetone (1:1) solution, stained
with Giemsa and counted manually.
Mammary Fat Pad Transplantation Assays
Basal cells were sorted and 25–1,000 cells were placed in 15 ml
of HBSS (Invitrogen) supplemented with 1% FCS and 25%
MatrigelTM Basement Membrane Matrix Growth Factor Reduced
(BD). Mammary fat pad clearing and transplantation was
performed on four-week-old CD1-Foxn12/2(nu/nu) nude female
Figure 4. Stat3 is required to maintain the multipotency of mammary stem cells and their proliferative potential. (A) Whole mount
staining of mammary outgrowths originating from CD24+ CD49fhi basal cells sorted from mammary glands of 5-week-old Stat3fl/fl,K14-Cre2 and
Stat3fl/fl;K14-Cre+ females. (B) Limiting dilution analysis to assess the repopulating frequency of the mammary stem cell-enriched population sorted
from mammary glands of 5-week-old Stat3fl/fl,K14-Cre2 and Stat3fl/fl;K14-Cre+ females. Number of outgrowths per number of transplanted fat pads
and percentage of fat pad filled 6 standard error of the mean are shown. CI: confidence interval. (C) H&E staining of mammary outgrowths
originating from CD24+ CD49fhi basal cells sorted from mammary glands of 5-week-old Stat3fl/fl;K14-Cre2 and Stat3fl/fl;K14-Cre+ females. (D, E)
Immunohistochemistry staining for pStat5 (red, D), Ki67 (red, E) and E-cadherin (green) in mammary outgrowths originating from CD24+ CD49fhi cells
from mammary glands of 5-week-old Stat3fl/fl,K14-Cre2 and Stat3fl/fl;K14-Cre+ females. Nuclei were stained with Hoechst 33342 (blue).
doi:10.1371/journal.pone.0052608.g004
Stat3 and Mammary Stem Cells
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mice (Charles River Lab). Mammary glands were collected 5
weeks after transplantation and processed as for whole mounts.
Results and Discussion
In order to investigate the role of Stat3 in adult mammary gland
stem cells, we determined initially if Stat3 is expressed in FACS
sorted populations of mammary epithelial cells using RT-PCR.
We detected Stat3 transcripts in all populations of cells tested
including the mammary stem cell-enriched subpopulation of basal
cells (mammary repopulating units, MRU), basal, luminal and
luminal progenitor (CD61+) cells (Fig. 1A). As the b-lactoglobulin
(BLG) promoter is activated primarily in the alveolar luminal
epithelial cells of the mammary gland [27] and full recombination
is achieved during lactation [25], we then used Stat3fl/fl, BLG-Cre+
mice to conditionally delete Stat3 in luminal mammary epithelium
[11]. Since BLG-Cre and WAP-Cre drive recombination in the
same populations of cells, deletion of Stat3 should occur also in PI-
MECs following involution. In virgin animals, BLG is not widely
expressed and drives recombination primarily in luminal ER2
progenitors, although recombination occurs in basal cells in both
older (42-week-old) and parous (21-week-old) females [28]. In
order to obtain maximum deletion of Stat3, Stat3fl/fl;BLG-Cre+
females were taken through a pregnancy/lactation/involution
cycle. Precocious development is evident during a second gestation
in Stat3fl/fl;BLG-Cre+ females with more alveolar structures and a
reduced area occupied by adipocytes (Fig. 1B). This could reflect
the retention of alveoli following involution or may be a
consequence of effects downstream of Stat3 depletion on
mammary stem and/or progenitor cells in terms of their number
and functionality, thus resulting in alterations in the development
of the gland during a second pregnancy. To discriminate between
these possibilities we analysed mammary glands of Stat3fl/fl;BLG-
Cre2 and Stat3fl/fl;BLG-Cre+ females after a ‘‘full involution’’ (four
weeks after natural weaning). Strikingly, at this time point, glands
with epithelial ablation of Stat3 showed incomplete involution
with more intact alveolar structures and less adipose tissue
compared to Stat3fl/fl;BLG-Cre2 glands (Fig. 1C, Fig. S1).
Moreover, we observed moderately to markedly ectatic ducts
with normal cuboidal epithelium attenuated in the distended ducts
(Fig. 1C). Analysis of protein levels revealed that glands from
Stat3fl/fl;BLG-Cre+ females have markedly increased levels of
phospho-Stat5 (pStat5) and the milk proteins b-casein and whey
acidic protein (WAP) (Fig. 1D, E). Normally, phosphorylation of
Stat5 occurs during pregnancy and reaches the highest level in late
gestation and early lactation [29]. This activation pattern is
associated with an essential role for Stat5 in lobuloalveolar
development [30,31]. Furthermore, Stat5 was shown to be a
survival factor during both involution and pregnancy [31,32].
Thus, we speculate that the delayed involution observed in Stat3fl/
fl;BLG-Cre+ mice four weeks after natural weaning is partially a
consequence of a pro-survival signal conveyed by activated Stat5,
which also induces expression of milk proteins such as WAP and b-
casein. However, Stat5 is required also for specification of early
progenitors [33]. Therefore another possible interpretation is that
deletion of Stat3 from basal MaSCs could result in precocious
activation of Stat5, diminishing self-renewal potential and
favouring specification of luminal progenitors.
Next we were interested in whether Stat3 deletion in mammary
epithelium affects the relative numbers of different types of
epithelial cells. To address this question, single-cell suspensions
from Stat3fl/fl;BLG-Cre2 and Stat3fl/fl;BLG-Cre+ mammary glands
four weeks after natural weaning were prepared, cells were stained
for CD24, CD49f and CD61 antigens and analysed using flow
cytometry [20,23]. The following populations were distinguished
within lineage negative (CD312 CD452 Ter1192) mammary cells
in glands of both genotypes: CD242 CD49f- stromal cells, CD24+
CD49flo luminal cells, and CD24+ CD49fhi basal cells. Analysis of
cell populations revealed that glands from Stat3fl/fl;BLG-Cre+ mice
did not show any difference in the number of luminal and basal
cells (Fig. S2A, B). However, the population of CD24+ CD49flo
CD61+ luminal progenitor cells was significantly reduced in Stat3fl/
fl;BLG-Cre+ females (Fig. 1F). CD61-positive luminal cells are
luminal progenitors that have colony-forming capacity in vitro [23].
Thus we assessed the impact of Stat3 deletion on the proliferative
potential of luminal CD61+ progenitors in in vitro colony forming
assays on a feeder layer of irradiated fibroblasts [23]. Surprisingly,
CD61+ luminal progenitors isolated from Stat3fl/fl;BLG-Cre+ glands
four weeks after natural weaning showed significantly reduced
capacity to form colonies compared to cells isolated from the
Stat3fl/fl;BLG-Cre2 glands (Fig. 1G). This may be a consequence of
the reduced levels of pAkt and pErk that are present in cells
deficient in Stat3 (Fig. 1D) and suggests that Stat3 plays a crucial
role in maintenance of the proliferative capacity of CD24+
CD49flo CD61+ luminal progenitors. This result is all the more
remarkable given that full deletion of both Stat3 alleles was not
obtained in cells from these Stat3fl/fl;BLG-Cre+ mice (Fig. S3),
suggesting biological selection against loss of the second Stat3
allele.
To assess the ability of mammary stem cells to repopulate the fat
pad and form a normal mammary epithelial network in the
absence of Stat3, the CD24+ CD49fhi basal cells, which contain
MaSCs, were sorted from glands of Stat3fl/fl;BLG-Cre2 and Stat3fl/
fl;BLG-Cre+ females four weeks after natural weaning and cells were
transplanted into cleared fat pads of immunocompromised nude
mice. The outgrowths were analysed after five weeks. MaSCs
isolated from both Stat3fl/fl;BLG-Cre2 and Stat3fl/fl;BLG-Cre+ mice
were able to repopulate fat pads and generated ductal outgrowths
with side branches (Fig. 2A). However, the outgrowths originating
from Stat3fl/fl;BLG-Cre+ cells were phenotypically different and
displayed more side branching than those from Stat3fl/fl;BLG-Cre2
cells. Limiting dilution transplantation assays were performed and
analysed using Extreme Limiting Dilution Analysis software
(http://bioinf.wehi.edu.au/software/elda/) [34]. These data
showed that the repopulating frequency of the CD24+ CD49fhi
MaSC-enriched population from Stat3fl/fl;BLG-Cre+ mice was four-
fold lower than that of the Stat3fl/fl;BLG-Cre2 cells after
transplantation (Fig. 2B). In order to confirm that these outgrowths
originated from mammary stem cells with long-term repopulating
capacity, we performed secondary fat pad transplantation
experiments. Primary outgrowths obtained from injection of
1,000 basal cells from Stat3fl/fl;BLG-Cre2 or Stat3fl/fl;BLG-Cre+
glands into cleared fat pads were collected and enzymatically
dispersed. Subsequently, 20,000 cells from single cell suspensions
were injected into the cleared fat pads of immunocompromised
mice. After five weeks, the fat pads were checked for secondary
outgrowths. We did not observe any differences in terms of the
number of outgrowths or their size between Stat3fl/fl;BLG-Cre2 and
Stat3fl/fl;BLG-Cre+ groups (Fig. S4). This suggests that, although
there were fewer MaSCs in Stat3fl/fl;BLG-Cre+ glands following
involution, mammary stem cells from both Stat3fl/fl;BLG-Cre2 and
Stat3fl/fl;BLG-Cre+ glands have a similar self-renewal potential.
Interpretation of the fat pad transplantation data from parous
Stat3fl/fl;BLG-Cre mice is confounded by the possibility that
outgrowths originated either from MaSCs that had activated the
BLG promoter and deleted the Stat3 gene or from PI-MECs that
have multipotent properties, can give rise to outgrowths upon
transplantation, and express basal population markers [18,19]. In
Stat3 and Mammary Stem Cells
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order to further refine our investigation of a role for Stat3 in
MaSCs so as to exclude PI-MECs we utilized a K14-Cre transgene
crossed with Stat3fl/fl mice. This experimental setting allowed
conditional Stat3 deletion in all K14 expressing cells in the
embryo. Recently, Van Keymeulen and coworkers demonstrated
that embryonic K14+ mammary stem/progenitor cells give rise to
all mammary epithelial cell lineages [35]. Stat3fl/fl;K14-Cre+ mice
do not show any phenotypic changes compared to their Stat3fl/
fl;K14-Cre2 counterparts and pre-pubertal mammary gland devel-
opment progresses normally regardless of Stat3 deletion in K14-
expressing cells (Fig. 3A, B). Moreover, Stat3fl/fl;K14-Cre+ dams do
not exhibit any lactation defects and can nurse pups normally
(data not shown). This could be due to sufficient expression of
Stat3 from the undeleted alleles (Fig. S5). However, transplanta-
tion of the CD24+ CD49fhi basal cells sorted from glands of Stat3fl/
fl;K14-Cre2 and Stat3fl/fl;K14-Cre+ females into cleared fat pads of
immunocompromised nude mice revealed striking differences in
the extent of fat pad filling with the Stat3 depleted cells giving rise
to very small outgrowths that did not fill the fat pad regardless of
the number of cells transplanted (Fig. 4A, B).This suggests a
diminished ability of Stat3 depleted stem cells to proliferate.
Secondly, the structure of the glands was different with normal
ductal branching evident for the control transplants but a lack of
long ducts coupled with disorganised highly branched lobular
structures apparent in the Stat3fl/fl;K14-Cre+ outgrowths in both
whole mounts and H&E stained sections (Fig. 4A, C). These are
similar to the outgrowths obtained from cells of the Stat3fl/fl;BLG-
Cre+ mice. This phenotype is reminiscent of that observed
following transplantation of PI-MECs which frequently exhibit
lobule-lineage restricted growth [36]. Moreover, this phenotype is
apparent throughout the transplanted glands suggesting that
reduction in the amount of Stat3 is sufficient to promote
commitment to the alveolar lineage at the expense of the ductal
lineage. This speculation is supported by analysis of nuclear pStat5
which is elevated in the outgrowths of Stat3fl/fl;K14-Cre+ females
compared to Stat3fl/fl;K14-Cre2 females (Fig. 4D) as observed also
for the fully involuted Stat3fl/fl;BLG-Cre+ glands. However, levels of
proliferation were not significantly different in Stat3fl/fl;K14-Cre+
and Stat3fl/fl;K14-Cre2 outgrowths (Fig. 4E). These data indicate
that the multipotent capacity of basal cells, which is lost following
birth, cannot be re-acquired when Stat3 is depleted suggesting that
Stat3 could be required for reprogramming adult mammary stem
cells to their multipotent state. In vitro culture of basal cells isolated
from Stat3fl/fl;K14-Cre2 virgin glands in 3D Matrigel organoid
culture [37] gave rise to branched solid organoids as expected
while basal cells from Stat3fl/fl;K14-Cre+ glands produced rounded
hollow organoids, similar to those formed by luminal cells (data
not shown). In the light of these data, we suggest that Stat3 is also
important for the maintenance of luminal progenitor proliferative
potential.
Supporting Information
Figure S1 Incomplete involution of mammary glands
with BLG-Cre mediated epithelial ablation of Stat3.
Whole mount staining of mammary glands of Stat3fl/fl;BLG-Cre2
and Stat3fl/fl;BLG-Cre+ females, collected four weeks after natural
weaning.
(TIF)
Figure S2 BLG-Cre mediated epithelial ablation of Stat3
does not affect the number of luminal and basal cells.
Flow cytometry analysis of luminal (A) and basal (B) cells isolated
from mammary glands of Stat3fl/fl;BLG-Cre2 and Stat3fl/fl;BLG-Cre+
females four weeks after natural weaning. Points represent the
value for each mouse and lines depict mean values for each group.
p value was determined using Student’s t test. ns: not significant.
(TIF)
Figure S3 Analysis of Stat3 alleles in mammary gland
cell populations from Stat3fl/fl;BLG-Cre mice. (A) Repre-
sentative gel showing Stat3 floxed and deleted alleles in genomic
DNA isolated from unsorted and sorted basal, luminal, stromal
and lineage positive (Lin+) cells from mammary glands of Stat3fl/
fl;BLG-Cre2 (C) and Stat3fl/fl;BLG-Cre+ (KO) females four weeks
after natural weaning. Different amounts of genomic DNA were
used for each PCR reaction. (B) Quantification of the Stat3 deleted
to floxed alleles ratio in unsorted and sorted basal and luminal cells
from panel A.
(TIF)
Figure S4 Mammary stem cells from Stat3fl/fl;BLG-Cre2
and Stat3fl/fl;BLG-Cre+ mice have similar long-term
repopulating capacity. (A) Whole mount staining of secondary
outgrowths obtained after injection of 20,000 cells from the
mammary glands arising from primary outgrowths of Stat3fl/
fl;BLG-Cre2 and Stat3fl/fl;BLG-Cre+ cells transplanted into cleared
fat pads. (B) Number of secondary outgrowths per number of
transplanted fat pads.
(TIF)
Figure S5 Analysis of Stat3 alleles in skin and mamma-
ry gland cell populations from Stat3fl/fl;K14-Cremice. (A,
B) Representative gels showing Stat3 floxed and deleted alleles in
genomic DNA isolated from skin (A), mammary gland tissue and
sorted basal and luminal mammary cells (B) from 5-week-old
Stat3fl/fl;K14-Cre2 (C) and Stat3fl/fl;K14-Cre+ (KO) females. Differ-
ent amounts of genomic DNA were used for each PCR reaction.
(C) Quantification of the Stat3 deleted to floxed alleles ratio in skin,
mammary tissue and sorted basal and luminal cells from panels A
and B.
(TIF)
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